25 XP   0   0   10

TherapeuticsMD Inc
Buy, Hold or Sell?

Let's analyse Therapeuticsmd together

PenkeI guess you are interested in TherapeuticsMD Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of TherapeuticsMD Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about TherapeuticsMD Inc

I send you an email if I find something interesting about TherapeuticsMD Inc.

Quick analysis of Therapeuticsmd (30 sec.)










What can you expect buying and holding a share of Therapeuticsmd? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$2.54
Expected worth in 1 year
$5.01
How sure are you?
27.5%

+ What do you gain per year?

Total Gains per Share
$2.47
Return On Investment
131.3%

For what price can you sell your share?

Current Price per Share
$1.88
Expected price per share
$0 - $2
How sure are you?
50%

1. Valuation of Therapeuticsmd (5 min.)




Live pricePrice per Share (EOD)

$1.88

Intrinsic Value Per Share

$-72.96 - $61.66

Total Value Per Share

$-70.42 - $64.20

2. Growth of Therapeuticsmd (5 min.)




Is Therapeuticsmd growing?

Current yearPrevious yearGrowGrow %
How rich?$29.2m-$53.5m$83.6m277.6%

How much money is Therapeuticsmd making?

Current yearPrevious yearGrowGrow %
Making money-$2.5m$2.8m-$5.4m-212.0%
Net Profit Margin1,194.8%-26.5%--

How much money comes from the company's main activities?

3. Financial Health of Therapeuticsmd (5 min.)




What can you expect buying and holding a share of Therapeuticsmd? (5 min.)

Welcome investor! Therapeuticsmd's management wants to use your money to grow the business. In return you get a share of Therapeuticsmd.

What can you expect buying and holding a share of Therapeuticsmd?

First you should know what it really means to hold a share of Therapeuticsmd. And how you can make/lose money.

Speculation

The Price per Share of Therapeuticsmd is $1.88. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Therapeuticsmd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Therapeuticsmd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $2.54. Based on the TTM, the Book Value Change Per Share is $0.62 per quarter. Based on the YOY, the Book Value Change Per Share is $2.23 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Therapeuticsmd.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.08-4.1%-0.24-12.8%0.7338.6%-2.42-128.7%-2.25-119.5%
Usd Book Value Change Per Share-0.08-4.4%0.6232.8%2.23118.7%-0.33-17.8%-0.07-3.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.08-4.4%0.6232.8%2.23118.7%-0.33-17.8%-0.07-3.5%
Usd Price Per Share2.25-3.29-5.64-2.90-4.52-
Price to Earnings Ratio-7.35--4.25--1.12--1.15--0.99-
Price-to-Total Gains Ratio-27.50--22.03--0.28--4.79--3.54-
Price to Book Ratio0.89-1.17-18.07-3.98-2.37-
Price-to-Total Gains Ratio-27.50--22.03--0.28--4.79--3.54-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.88
Number of shares531
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.62-0.33
Usd Total Gains Per Share0.62-0.33
Gains per Quarter (531 shares)327.60-177.42
Gains per Year (531 shares)1,310.39-709.66
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10131013000-710-720
20262126100-1419-1430
30393139200-2129-2140
40524252300-2839-2850
50655265400-3548-3560
60786278500-4258-4270
70917391600-4968-4980
8010483104700-5677-5690
9011794117800-6387-6400
10013104130900-7097-7110

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%1.019.00.05.0%1.039.00.02.5%33.067.00.033.0%
Book Value Change Per Share1.03.00.025.0%4.08.00.033.3%5.015.00.025.0%11.029.00.027.5%49.046.05.049.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.0100.00.0%
Total Gains per Share1.03.00.025.0%4.08.00.033.3%5.015.00.025.0%11.029.00.027.5%49.046.05.049.0%

Fundamentals of Therapeuticsmd

About TherapeuticsMD Inc

TherapeuticsMD, Inc. operates as a pharmaceutical company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY,BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

Fundamental data was last updated by Penke on 2024-04-12 20:49:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of TherapeuticsMD Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Therapeuticsmd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Therapeuticsmd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -175.9% means that $-1.76 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of TherapeuticsMD Inc:

  • The MRQ is -175.9%. The company is making a huge loss. -2
  • The TTM is 1,194.8%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ-175.9%TTM1,194.8%-1,370.7%
TTM1,194.8%YOY-26.5%+1,221.3%
TTM1,194.8%5Y10.6%+1,184.2%
5Y10.6%10Y-249.1%+259.7%
1.1.2. Return on Assets

Shows how efficient Therapeuticsmd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Therapeuticsmd to the Drug Manufacturers - Specialty & Generic industry mean.
  • -2.0% Return on Assets means that Therapeuticsmd generated $-0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of TherapeuticsMD Inc:

  • The MRQ is -2.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -4.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-2.0%TTM-4.8%+2.8%
TTM-4.8%YOY0.7%-5.5%
TTM-4.8%5Y-13.2%+8.4%
5Y-13.2%10Y-16.2%+2.9%
1.1.3. Return on Equity

Shows how efficient Therapeuticsmd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Therapeuticsmd to the Drug Manufacturers - Specialty & Generic industry mean.
  • -3.0% Return on Equity means Therapeuticsmd generated $-0.03 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of TherapeuticsMD Inc:

  • The MRQ is -3.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -8.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.0%TTM-8.5%+5.5%
TTM-8.5%YOY0.4%-8.9%
TTM-8.5%5Y-65.9%+57.4%
5Y-65.9%10Y-45.1%-20.7%

1.2. Operating Efficiency of TherapeuticsMD Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Therapeuticsmd is operating .

  • Measures how much profit Therapeuticsmd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Therapeuticsmd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -320.9% means the company generated $-3.21  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of TherapeuticsMD Inc:

  • The MRQ is -320.9%. The company is operating very inefficient. -2
  • The TTM is 290.5%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ-320.9%TTM290.5%-611.4%
TTM290.5%YOY-75.2%+365.7%
TTM290.5%5Y-146.1%+436.6%
5Y-146.1%10Y-325.1%+179.1%
1.2.2. Operating Ratio

Measures how efficient Therapeuticsmd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 4.21 means that the operating costs are $4.21 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of TherapeuticsMD Inc:

  • The MRQ is 4.209. The company is inefficient in keeping operating costs low. -1
  • The TTM is -4.068.
Trends
Current periodCompared to+/- 
MRQ4.209TTM-4.068+8.277
TTM-4.068YOY1.678-5.746
TTM-4.0685Y2.027-6.095
5Y2.02710Y4.048-2.021

1.3. Liquidity of TherapeuticsMD Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Therapeuticsmd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.38 means the company has $1.38 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of TherapeuticsMD Inc:

  • The MRQ is 1.381. The company is just able to pay all its short-term debts.
  • The TTM is 1.307. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.381TTM1.307+0.074
TTM1.307YOY2.857-1.550
TTM1.3075Y2.544-1.237
5Y2.54410Y5.852-3.308
1.3.2. Quick Ratio

Measures if Therapeuticsmd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Therapeuticsmd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.08 means the company can pay off $1.08 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of TherapeuticsMD Inc:

  • The MRQ is 1.082. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.008. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.082TTM1.008+0.074
TTM1.008YOY2.837-1.829
TTM1.0085Y2.304-1.295
5Y2.30410Y5.567-3.264

1.4. Solvency of TherapeuticsMD Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Therapeuticsmd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Therapeuticsmd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.32 means that Therapeuticsmd assets are financed with 32.4% credit (debt) and the remaining percentage (100% - 32.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of TherapeuticsMD Inc:

  • The MRQ is 0.324. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.412. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.324TTM0.412-0.089
TTM0.412YOY1.163-0.751
TTM0.4125Y1.052-0.640
5Y1.05210Y0.614+0.438
1.4.2. Debt to Equity Ratio

Measures if Therapeuticsmd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Therapeuticsmd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 47.9% means that company has $0.48 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of TherapeuticsMD Inc:

  • The MRQ is 0.479. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.715. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.479TTM0.715-0.236
TTM0.715YOY0.016+0.699
TTM0.7155Y3.115-2.399
5Y3.11510Y1.694+1.421

2. Market Valuation of TherapeuticsMD Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Therapeuticsmd generates.

  • Above 15 is considered overpriced but always compare Therapeuticsmd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -7.35 means the investor is paying $-7.35 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of TherapeuticsMD Inc:

  • The EOD is -6.138. Based on the earnings, the company is expensive. -2
  • The MRQ is -7.346. Based on the earnings, the company is expensive. -2
  • The TTM is -4.250. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6.138MRQ-7.346+1.208
MRQ-7.346TTM-4.250-3.096
TTM-4.250YOY-1.124-3.127
TTM-4.2505Y-1.146-3.104
5Y-1.14610Y-0.986-0.160
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of TherapeuticsMD Inc:

  • The EOD is -0.691. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.827. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.630. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.691MRQ-0.827+0.136
MRQ-0.827TTM-1.630+0.802
TTM-1.630YOY119.660-121.290
TTM-1.6305Y23.529-25.159
5Y23.52910Y11.305+12.225
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Therapeuticsmd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of TherapeuticsMD Inc:

  • The EOD is 0.740. Based on the equity, the company is cheap. +2
  • The MRQ is 0.886. Based on the equity, the company is cheap. +2
  • The TTM is 1.168. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.740MRQ0.886-0.146
MRQ0.886TTM1.168-0.282
TTM1.168YOY18.070-16.901
TTM1.1685Y3.980-2.812
5Y3.98010Y2.373+1.608
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of TherapeuticsMD Inc.

3.1. Institutions holding TherapeuticsMD Inc

Institutions are holding 36.439% of the shares of TherapeuticsMD Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Rubric Capital Management LP11.27340.0557119219100
2023-12-31Clearline Capital LP4.40850.0643466211108232.3767
2023-12-31Tejara Capital Ltd3.80070.3788401937323438.751
2023-12-31Vanguard Group Inc3.665038758223340.6058
2023-12-31ADAR1 Capital Management LLC2.57360.21882721602721600
2023-12-31BlackRock Inc1.28850136263-242-0.1773
2023-12-31Morgan Stanley - Brokerage Accounts1.2460131767-1377-1.0342
2023-12-31Geode Capital Management, LLC0.801808478800
2023-12-31Bridgeway Capital Management, LLC0.39720.0024200000
2023-12-31State Street Corporation0.2846030100-28-0.0929
2023-12-31Gabelli Funds LLC0.27420.000529000-2000-6.4516
2023-12-31Ameriprise Financial Inc0.2126022479-17-0.0756
2023-12-31Northern Trust Corp0.155901649100
2023-12-31J. Goldman & Co LP0.12820.00121356200
2023-12-31Dimensional Fund Advisors, Inc.0.09601015400
2023-12-31FMR Inc0.078408289-3-0.0362
2023-12-31AJOVista LLC0.02030.0061215121510
2023-12-31UBS Group AG0.0120127257582.4964
2023-12-31Banque Cantonale Vaudoise0.00950.0001100000
2023-12-31Bank of America Corp0.00390409-8101-95.1939
Total 30.73030.72753249806+308618+9.5%

3.2. Funds holding TherapeuticsMD Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv2.1648024965700
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.05990.000312223400
2024-02-29Fidelity Extended Market Index0.42330.000348817-237-0.4831
2023-12-31Bridgeway Ultra-Small Company Market0.36420.05094200000
2023-09-30BlackRock Extended Mkt Composite0.1620.00041868600
2024-03-28iShares Micro-Cap ETF0.15940.00461838200
2023-12-31GDL Fund0.14740.0211700000
2024-03-31BlackRock Extended Equity Market K0.14140.00031630860.0368
2024-02-29Fidelity Total Market Index0.128601483500
2024-02-29Fidelity Series Total Market Index0.098201132000
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.07590.0003875600
2023-12-31Gabelli ABC AAA0.06940.00498000-2000-20
2024-02-29Schwab Total Stock Market Index0.06120.0001706000
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.0610.00037032130.1852
2024-02-29Fidelity OTC0.05920.0001682600
2024-02-29DFA US Core Equity 2 I0.05760.0001663900
2023-12-31Northern Trust Extended Eq Market Idx0.05690.0003656700
2023-12-31NT Ext Equity Mkt Idx Fd - L0.05690.0003656700
2024-02-29Vanguard Instl Ttl Stk Mkt Idx InstlPls0.04760548600
2023-10-31Vanguard Instl Ttl Stck Mkt Idx Tr0.047605486-244171-97.8026
Total 5.44250.0842627658-246389-39.3%

3.3. Insider Transactions

Insiders are holding 4.124% of the shares of TherapeuticsMD Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-12-06Marlan D WalkerSELL145002.31
2023-04-12Marlan D WalkerSELL11703.65

4. Summary

4.1. Key Performance Indicators

The key performance indicators of TherapeuticsMD Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.0820.617-113%2.231-104%-0.334+308%-0.066-20%
Book Value Per Share--2.5402.785-9%-5.063+299%-2.971+217%3.271-22%
Current Ratio--1.3811.307+6%2.857-52%2.544-46%5.852-76%
Debt To Asset Ratio--0.3240.412-22%1.163-72%1.052-69%0.614-47%
Debt To Equity Ratio--0.4790.715-33%0.016+2859%3.115-85%1.694-72%
Dividend Per Share----0%-0%-0%-0%
Eps---0.077-0.240+214%0.726-111%-2.419+3059%-2.246+2834%
Free Cash Flow Per Share---0.680-0.597-12%-1.516+123%-2.766+307%-2.331+243%
Free Cash Flow To Equity Per Share---0.506-0.500-1%-4.004+691%-1.357+168%170.995-100%
Gross Profit Margin--1.0005.281-81%1.178-15%2.158-54%1.579-37%
Intrinsic Value_10Y_max--61.660--------
Intrinsic Value_10Y_min---72.962--------
Intrinsic Value_1Y_max---5.429--------
Intrinsic Value_1Y_min---9.042--------
Intrinsic Value_3Y_max---7.466--------
Intrinsic Value_3Y_min---25.828--------
Intrinsic Value_5Y_max--1.163--------
Intrinsic Value_5Y_min---41.021--------
Market Cap19881376.000-31%25947000.00035372711.000-27%59644128.000-56%30766638.644-16%47828032.922-46%
Net Profit Margin---1.75911.948-115%-0.265-85%0.106-1754%-2.491+42%
Operating Margin---3.2092.905-210%-0.752-77%-1.461-54%-3.251+1%
Operating Ratio--4.209-4.068+197%1.678+151%2.027+108%4.048+4%
Pb Ratio0.740-20%0.8861.168-24%18.070-95%3.980-78%2.373-63%
Pe Ratio-6.138+16%-7.346-4.250-42%-1.124-85%-1.146-84%-0.986-87%
Price Per Share1.880-20%2.2503.285-32%5.640-60%2.897-22%4.517-50%
Price To Free Cash Flow Ratio-0.691+16%-0.827-1.630+97%119.660-101%23.529-104%11.305-107%
Price To Total Gains Ratio-22.981+16%-27.503-22.028-20%-0.281-99%-4.786-83%-3.538-87%
Quick Ratio--1.0821.008+7%2.837-62%2.304-53%5.567-81%
Return On Assets---0.020-0.048+136%0.007-403%-0.132+549%-0.162+693%
Return On Equity---0.030-0.085+182%0.004-929%-0.659+2085%-0.451+1397%
Total Gains Per Share---0.0820.617-113%2.231-104%-0.334+308%-0.066-20%
Usd Book Value--29287000.00030140000.000-3%-53539286.500+283%-31285191.850+207%34655748.075-15%
Usd Book Value Change Per Share---0.0820.617-113%2.231-104%-0.334+308%-0.066-20%
Usd Book Value Per Share--2.5402.785-9%-5.063+299%-2.971+217%3.271-22%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.077-0.240+214%0.726-111%-2.419+3059%-2.246+2834%
Usd Free Cash Flow---7841000.000-6490500.000-17%-16034323.500+104%-29283670.250+273%-24674019.150+215%
Usd Free Cash Flow Per Share---0.680-0.597-12%-1.516+123%-2.766+307%-2.331+243%
Usd Free Cash Flow To Equity Per Share---0.506-0.500-1%-4.004+691%-1.357+168%170.995-100%
Usd Market Cap19881376.000-31%25947000.00035372711.000-27%59644128.000-56%30766638.644-16%47828032.922-46%
Usd Price Per Share1.880-20%2.2503.285-32%5.640-60%2.897-22%4.517-50%
Usd Profit---883000.000-2569500.000+191%2878512.750-131%-26542404.250+2906%-24239007.950+2645%
Usd Revenue--502000.000325500.000+54%17228527.000-97%13584316.250-96%8977226.625-94%
Usd Total Gains Per Share---0.0820.617-113%2.231-104%-0.334+308%-0.066-20%
 EOD+3 -5MRQTTM+13 -21YOY+13 -215Y+23 -1110Y+16 -18

4.2. Fundamental Score

Let's check the fundamental score of TherapeuticsMD Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-6.138
Price to Book Ratio (EOD)Between0-10.740
Net Profit Margin (MRQ)Greater than0-1.759
Operating Margin (MRQ)Greater than0-3.209
Quick Ratio (MRQ)Greater than11.082
Current Ratio (MRQ)Greater than11.381
Debt to Asset Ratio (MRQ)Less than10.324
Debt to Equity Ratio (MRQ)Less than10.479
Return on Equity (MRQ)Greater than0.15-0.030
Return on Assets (MRQ)Greater than0.05-0.020
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of TherapeuticsMD Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5025.497
Ma 20Greater thanMa 502.109
Ma 50Greater thanMa 1002.248
Ma 100Greater thanMa 2002.294
OpenGreater thanClose1.870
Total0/5 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Net Debt  -295-8,377-8,6723,330-5,3423,380-1,9625,6403,678
Income Tax Expense  21,2911,293-1,1451482,1762,324-2,367-43



Latest Balance Sheet

Balance Sheet of 2023-12-31. All numbers in thousands.

Summary
Total Assets43,309
Total Liabilities14,022
Total Stockholder Equity29,287
 As reported
Total Liabilities 14,022
Total Stockholder Equity+ 29,287
Total Assets = 43,309

Assets

Total Assets43,309
Total Current Assets9,462
Long-term Assets33,847
Total Current Assets
Cash And Cash Equivalents 4,327
Net Receivables 3,090
Other Current Assets 2,045
Total Current Assets  (as reported)9,462
Total Current Assets  (calculated)9,462
+/-0
Long-term Assets
Property Plant Equipment 6,873
Long-term Assets Other 8,490
Long-term Assets  (as reported)33,847
Long-term Assets  (calculated)15,363
+/- 18,484

Liabilities & Shareholders' Equity

Total Current Liabilities6,854
Long-term Liabilities7,168
Total Stockholder Equity29,287
Total Current Liabilities
Short-term Debt 1,473
Accounts payable 27
Other Current Liabilities 5,354
Total Current Liabilities  (as reported)6,854
Total Current Liabilities  (calculated)6,854
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)7,168
Long-term Liabilities  (calculated)0
+/- 7,168
Total Stockholder Equity
Common Stock11
Retained Earnings -949,641
Other Stockholders Equity 978,917
Total Stockholder Equity (as reported)29,287
Total Stockholder Equity (calculated)29,287
+/-0
Other
Cash and Short Term Investments 4,327
Common Stock Shares Outstanding 11,532
Liabilities and Stockholders Equity 43,309
Net Debt 3,678
Net Working Capital 2,608
Short Long Term Debt Total 8,005



Balance Sheet

All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-31
> Total Assets 
0
0
0
498
515
528
562
628
672
704
732
695
713
692
702
753
809
820
858
898
923
950
1,039
1,089
1,183
1,183
1,405
1,808
1,549
1,690
1,873
1,867
1,925
1,924
2,036
495
495
122
64
54
28
8
690
850
840
1,467
511
467
467
5
7
1,439
1,488
4,878
3,515
5,818
44,192
43,066
68,477
62,016
53,570
44,430
74,608
59,079
99,482
75,679
90,460
73,729
192,969
176,588
158,822
142,472
124,421
106,878
160,361
143,230
122,962
171,899
236,753
211,984
181,892
246,553
249,962
265,986
268,641
205,539
177,291
181,610
239,306
210,601
209,628
169,472
133,381
146,202
133,907
809
59,601
53,689
50,493
43,309
43,30950,49353,68959,601809133,907146,202133,381169,472209,628210,601239,306181,610177,291205,539268,641265,986249,962246,553181,892211,984236,753171,899122,962143,230160,361106,878124,421142,472158,822176,588192,96973,72990,46075,67999,48259,07974,60844,43053,57062,01668,47743,06644,1925,8183,5154,8781,4881,439754674675111,46784085069082854641224954952,0361,9241,9251,8671,8731,6901,5491,8081,4051,1831,1831,0891,039950923898858820809753702692713695732704672628562528515498000
   > Total Current Assets 
0
0
0
109
136
160
204
290
338
381
401
409
435
372
390
436
492
425
405
369
336
343
188
367
467
531
678
1,060
803
917
1,150
1,111
1,158
1,170
1,253
495
495
122
64
54
28
8
81
70
65
83
28
7
7
5
7
1,237
1,288
3,455
2,231
4,527
42,896
40,507
65,933
59,403
50,968
41,850
72,180
56,235
96,708
72,962
87,781
70,680
189,837
174,030
156,104
139,410
121,274
103,516
156,981
139,554
119,165
167,097
211,690
186,779
152,631
216,463
191,765
208,416
211,988
148,944
122,444
128,404
187,042
159,657
159,979
119,468
84,424
98,603
87,478
492
24,735
19,613
17,441
9,462
9,46217,44119,61324,73549287,47898,60384,424119,468159,979159,657187,042128,404122,444148,944211,988208,416191,765216,463152,631186,779211,690167,097119,165139,554156,981103,516121,274139,410156,104174,030189,83770,68087,78172,96296,70856,23572,18041,85050,96859,40365,93340,50742,8964,5272,2313,4551,2881,2377577288365708182854641224954951,2531,1701,1581,1111,1509178031,060678531467367188343336369405425492436390372435409401381338290204160136109000
       Cash And Cash Equivalents 
0
0
0
58
80
99
140
192
239
293
269
339
378
247
267
316
295
228
263
154
230
256
81
258
368
418
524
902
671
778
1,019
986
1,020
1,051
1,129
409
409
122
64
54
28
8
20
42
48
4
24
1
1
3
4
126
195
1,728
154
1,553
38,780
34,435
59,572
54,191
45,404
35,554
66,999
51,362
91,658
67,246
81,124
64,706
182,097
166,532
147,534
131,534
113,525
96,476
148,293
127,136
107,349
154,387
189,999
161,613
122,884
182,846
155,330
160,830
170,098
113,839
79,634
80,486
137,617
111,424
104,841
65,122
30,384
26,303
27,080
295
17,248
13,729
10,166
4,327
4,32710,16613,72917,24829527,08026,30330,38465,122104,841111,424137,61780,48679,634113,839170,098160,830155,330182,846122,884161,613189,999154,387107,349127,136148,29396,476113,525131,534147,534166,532182,09764,70681,12467,24691,65851,36266,99935,55445,40454,19159,57234,43538,7801,5531541,728195126431124448422082854641224094091,1291,0511,0209861,01977867190252441836825881256230154263228295316267247378339269293239192140998058000
       Short-term Investments 
0
0
0
4
6
5
6
6
6
6
63
5
4
73
59
62
68
86
43
126
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
68
0
68
68
68
0
0
00686868068000000000000000000000000000000000000000000000000000000000000000000000000012643866862597345636666564000
       Net Receivables 
0
0
0
3
54
4
4
4
5
81
69
65
53
52
64
58
76
84
68
81
106
87
106
110
99
112
155
158
132
139
132
125
137
119
124
87
87
0
0
0
0
0
0
11
15
9
4
6
6
0
2
27
112
408
270
607
603
958
1,794
1,691
2,339
2,165
2,399
2,154
2,644
3,563
3,667
3,050
5,064
4,477
5,033
4,501
3,921
3,396
4,393
4,329
5,097
5,626
12,803
11,064
14,945
18,383
15,324
24,396
20,664
18,291
24,059
32,382
33,719
33,481
37,402
36,176
35,413
45,804
32,157
76
2,041
1,038
3,134
3,090
3,0903,1341,0382,0417632,15745,80435,41336,17637,40233,48133,71932,38224,05918,29120,66424,39615,32418,38314,94511,06412,8035,6265,0974,3294,3933,3963,9214,5015,0334,4775,0643,0503,6673,5632,6442,1542,3992,1652,3391,6911,7949586036072704081122720664915110000008787124119137125132139132158155112991101068710681688476586452536569815444543000
       Other Current Assets 
0
0
0
0
-3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
62
17
2
70
0
0
0
2
1
496
438
499
332
752
2,176
3,607
3,420
2,478
2,304
2,678
100
1,537
1,446
904
2,121
2,234
1,718
2,137
2,693
2,299
2,488
2,229
3,002
6,604
5,098
5,204
6,510
10,835
9,847
7,739
10,578
11,330
6,618
6,642
8,819
7,543
4,912
3,978
3,715
10,548
5,712
20,346
5,586
2,533
5,446
1,447
3,509
2,045
2,0453,5091,4475,4462,5335,58620,3465,71210,5483,7153,9784,9127,5438,8196,6426,61811,33010,5787,7399,84710,8356,5105,2045,0986,6043,0022,2292,4882,2992,6932,1371,7182,2342,1219041,4461,5371002,6782,3042,4783,4203,6072,1767523324994384961200070217620000000000000000000000000000000000000-30000
   > Long-term Assets 
0
0
0
390
379
369
358
339
334
324
330
286
278
320
312
317
317
395
452
530
587
607
851
721
715
652
727
747
745
773
723
757
767
754
783
0
409
0
0
0
0
0
609
780
774
1,384
483
0
460
0
0
201
200
1,423
1,283
1,291
1,297
2,559
2,544
2,613
2,601
2,580
2,429
2,844
2,774
2,717
2,678
3,049
3,132
2,558
2,718
3,062
3,147
3,362
3,381
3,676
3,797
4,802
25,063
25,205
29,260
30,090
58,197
57,569
56,653
56,595
54,846
53,206
52,264
50,944
49,649
50,004
48,957
47,599
46,429
317
34,866
34,076
33,052
33,847
33,84733,05234,07634,86631746,42947,59948,95750,00449,64950,94452,26453,20654,84656,59556,65357,56958,19730,09029,26025,20525,0634,8023,7973,6763,3813,3623,1473,0622,7182,5583,1323,0492,6782,7172,7742,8442,4292,5802,6012,6132,5442,5591,2971,2911,2831,4232002010046004831,384774780609000004090783754767757723773745747727652715721851607587530452395317317312320278286330324334339358369379390000
       Property Plant Equipment 
0
0
0
390
379
369
358
339
334
324
330
286
278
320
312
317
317
395
452
530
587
607
851
721
715
652
727
747
745
773
723
757
767
754
783
0
0
0
0
0
0
0
609
383
760
225
192
172
172
0
0
70
88
107
95
66
84
76
47
61
78
77
70
63
56
65
57
199
265
444
461
517
511
484
448
437
426
404
382
473
669
1,432
12,798
12,617
12,087
12,484
11,946
11,508
11,017
10,485
9,779
9,433
9,157
8,624
8,300
317
7,464
7,267
7,074
6,873
6,8737,0747,2677,4643178,3008,6249,1579,4339,77910,48511,01711,50811,94612,48412,08712,61712,7981,432669473382404426437448484511517461444265199576556637077786147768466951078870001721721922257603836090000000783754767757723773745747727652715721851607587530452395317317312320278286330324334339358369379390000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
288
288
288
288
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000000000000000288288288288000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
478
0
0
0
0
0
19
31
68
107
240
317
345
488
666
757
867
842
1,229
1,259
1,294
1,324
1,615
1,695
1,984
2,118
2,406
2,497
2,740
2,793
3,100
3,221
3,488
23,772
24,093
24,456
24,688
44,926
44,480
44,093
43,665
42,497
41,445
40,994
40,206
39,617
40,318
39,547
38,721
37,876
6,943
6,877
6,767
6,657
0
06,6576,7676,8776,94337,87638,72139,54740,31839,61740,20640,99441,44542,49743,66544,09344,48044,92624,68824,45624,09323,7723,4883,2213,1002,7932,7402,4972,4062,1181,9841,6951,6151,3241,2941,2591,22984286775766648834531724010768311900000478000000000000000000000000000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-409
0
0
0
0
0
0
0
0
0
0
0
0
0
0
132
112
1,315
1,189
1,226
1,212
2,483
2,497
2,552
2,524
2,503
2,358
2,781
2,718
2,652
2,622
2,850
2,867
2,114
2,257
2,545
2,636
2,878
2,932
3,239
151
910
910
639
4,136
654
473
473
473
447
404
46,016
253
253
253
253
253
254
253
0
20,525
0
0
0
00020,525025325425325325325325346,0164044474734734736544,1366399109101513,2392,9322,8782,6362,5452,2572,1142,8672,8502,6222,6522,7182,7812,3582,5032,5242,5522,4972,4831,2121,2261,1891,31511213200000000000000-409000000000000000000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
759
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000759000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
0
0
0
18
24
22
19
16
21
21
32
23
20
17
18
17
49
25
26
32
40
40
73
37
57
48
158
493
176
240
267
180
183
117
136
78
78
45
33
36
38
33
535
1,161
1,498
2,344
1,359
1,375
1,375
357
437
3,151
4,840
5,582
7,848
7,251
4,250
4,599
6,390
7,318
6,819
6,947
11,008
10,690
11,766
12,674
12,902
10,666
9,596
9,339
12,468
14,983
14,087
13,288
10,877
13,321
15,660
94,354
102,538
114,460
121,198
238,459
271,191
256,785
313,850
299,628
293,324
305,611
248,784
259,675
266,988
263,093
273,961
172,268
182,178
49
27,577
22,492
22,441
14,022
14,02222,44122,49227,57749182,178172,268273,961263,093266,988259,675248,784305,611293,324299,628313,850256,785271,191238,459121,198114,460102,53894,35415,66013,32110,87713,28814,08714,98312,4689,3399,59610,66612,90212,67411,76610,69011,0086,9476,8197,3186,3904,5994,2507,2517,8485,5824,8403,1514373571,3751,3751,3592,3441,4981,161535333836334578781361171831802672401764931584857377340403226254917181720233221211619222418000
   > Total Current Liabilities 
0
0
0
18
24
22
19
16
21
21
32
23
20
17
18
17
49
25
26
32
40
40
73
37
57
48
102
434
116
178
204
115
117
49
67
78
78
45
33
36
38
33
535
1,161
1,498
2,344
1,359
1,375
1,375
357
437
3,151
2,629
2,488
4,428
3,512
4,250
4,599
6,390
7,318
6,819
6,947
11,008
10,690
11,115
11,707
11,688
10,666
9,596
9,339
12,468
14,983
14,087
13,288
10,877
13,321
15,660
21,212
29,277
41,079
44,973
41,876
67,330
53,005
61,639
46,484
47,330
59,238
61,284
75,675
86,266
252,891
264,835
163,986
174,071
49
19,336
14,364
14,512
6,854
6,85414,51214,36419,33649174,071163,986264,835252,89186,26675,67561,28459,23847,33046,48461,63953,00567,33041,87644,97341,07929,27721,21215,66013,32110,87713,28814,08714,98312,4689,3399,59610,66611,68811,70711,11510,69011,0086,9476,8197,3186,3904,5994,2503,5124,4282,4882,6293,1514373571,3751,3751,3592,3441,4981,1615353338363345787867491171152041781164341024857377340403226254917181720233221211619222418000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
23
23
23
23
0
0
0
0
0
0
0
0
0
0
0
300
600
800
0
0
754
754
309
365
2,150
1,349
449
2,249
0
100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
73,141
0
0
1,158
1,187
1,242
1,502
1,753
2,107
2,404
2,254
5,000
10,000
15,000
188,269
204,226
92,156
94,985
0
1,441
1,448
1,464
1,473
1,4731,4641,4481,441094,98592,156204,226188,26915,00010,0005,0002,2542,4042,1071,7531,5021,2421,1871,1580073,1410000000000000000000010002,2494491,3492,150365309754754008006003000000000000023232323200000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
73,141
0
0
1,158
0
0
0
0
0
0
0
5,000
10,000
15,000
188,269
202,857
90,780
93,602
0
0
0
0
0
0000093,60290,780202,857188,26915,00010,0005,00000000001,1580073,14100000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
14
19
18
15
11
17
17
14
18
17
15
16
15
43
18
19
21
26
35
55
28
47
28
31
38
46
31
88
59
58
34
39
0
7
12
1
4
6
1
0
229
359
677
1,008
0
580
3
15
307
608
692
1,031
1,641
1,841
2,045
2,472
2,114
3,069
2,330
5,649
6,327
6,235
5,819
5,302
3,126
3,431
3,039
4,224
7,359
6,146
8,108
4,199
4,098
6,284
11,427
11,382
22,744
25,365
19,499
24,134
19,181
28,714
17,270
16,110
21,068
10,310
14,565
19,592
20,318
20,753
13,978
13,383
43
2,326
1,508
696
27
276961,5082,3264313,38313,97820,75320,31819,59214,56510,31021,06816,11017,27028,71419,18124,13419,49925,36522,74411,38211,4276,2844,0984,1998,1086,1467,3594,2243,0393,4313,1265,3025,8196,2356,3275,6492,3303,0692,1142,4722,0451,8411,6411,03169260830715358001,0086773592290164112703934585988314638312847285535262119184315161517181417171115181914000
       Other Current Liabilities 
0
0
0
3
5
4
4
5
4
4
18
5
2
2
2
1
6
7
7
11
15
5
19
9
10
20
23
301
47
100
93
56
58
15
28
0
71
32
32
32
32
32
235
1
339
1,668
351
0
41
45
57
694
672
728
445
726
1,167
1,335
2,066
3,601
2,272
3,329
4,511
3,841
4,879
5,888
6,387
7,540
6,166
6,300
8,243
7,624
7,941
5,180
6,677
9,224
9,376
9,785
17,895
18,335
19,607
22,377
43,196
33,824
31,171
29,213
31,220
38,170
45,974
51,110
51,674
4,717
39,856
57,852
65,703
6
15,569
1,372
6,888
5,354
5,3546,8881,37215,569665,70357,85239,8564,71751,67451,11045,97438,17031,22029,21331,17133,82443,19622,37719,60718,33517,8959,7859,3769,2246,6775,1807,9417,6248,2436,3006,1667,5406,3875,8884,8793,8414,5113,3292,2723,6012,0661,3351,16772644572867269457454103511,668339123532323232327102815585693100473012320109195151177612225184454453000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
56
59
60
62
63
65
66
68
70
0
0
32
32
32
32
32
0
0
0
0
0
0
0
0
0
0
2,211
3,094
3,421
3,739
3,739
0
0
0
0
0
0
0
652
967
1,214
0
0
0
0
0
0
0
0
0
0
73,141
73,261
73,381
76,226
196,583
203,861
203,780
252,211
253,144
245,994
246,373
187,500
184,000
180,722
10,202
9,126
8,282
8,107
8,476
8,241
8,128
7,929
7,168
7,1687,9298,1288,2418,4768,1078,2829,12610,202180,722184,000187,500246,373245,994253,144252,211203,780203,861196,58376,22673,38173,26173,14100000000001,21496765200000003,7393,7393,4213,0942,211000000000032323232320070686665636260595600000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,211
3,094
3,342
3,589
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
73,141
73,261
73,381
73,501
194,095
194,361
194,635
243,429
243,802
237,051
237,698
178,970
175,261
171,738
0
0
0
0
0
0
0
0
0
000000000171,738175,261178,970237,698237,051243,802243,429194,635194,361194,09573,50173,38173,26173,1410000000000000000000003,5893,3423,0942,2110000000000000000000000000000000000000000000000000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
759
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000759000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
80
150
0
0
0
0
0
0
0
0
651
967
1,214
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
35
35
0
0
358
758
2,139
1,229
554
554
0
1,106
0
0
0
0001,10605545541,2292,1397583580035350000000000000000001,2149676510000000015080000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
759
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000759000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
480
491
506
543
612
651
683
699
672
694
675
684
736
760
795
831
866
883
910
965
1,051
1,125
1,135
1,246
1,314
1,372
1,450
1,606
1,687
1,742
1,807
1,900
0
418
77
31
19
-10
-25
155
-311
-658
-878
-848
0
-908
-351
-430
-1,712
-3,352
-704
-4,334
-1,433
39,943
38,467
62,087
54,698
46,751
37,483
63,601
48,389
87,716
63,005
77,557
63,063
183,372
167,249
146,354
127,489
110,334
93,590
149,485
129,909
107,302
77,545
134,215
97,524
60,693
8,094
-21,229
9,201
-45,209
-94,089
-116,034
-124,002
-9,478
-49,074
-57,360
-93,621
-140,580
-26,066
-48,271
760
32,024
31,197
28,052
29,287
29,28728,05231,19732,024760-48,271-26,066-140,580-93,621-57,360-49,074-9,478-124,002-116,034-94,089-45,2099,201-21,2298,09460,69397,524134,21577,545107,302129,909149,48593,590110,334127,489146,354167,249183,37263,06377,55763,00587,71648,38963,60137,48346,75154,69862,08738,46739,943-1,433-4,334-704-3,352-1,712-430-351-9080-848-878-658-311155-25-1019317741801,9001,8071,7421,6871,6061,4501,3721,3141,2461,1351,1251,051965910883866831795760736684675694672699683651612543506491480000
   Common Stock
0
0
0
59
59
59
59
59
59
59
59
63
63
63
63
63
63
63
63
62
62
62
62
62
62
62
62
62
62
62
62
62
62
62
62
0
62
112
112
102
102
102
1,567
1,579
1,579
1,629
16
0
17
17
17
83
85
96
100
100
129
131
145
145
145
146
156
156
173
173
178
178
196
196
197
197
199
204
216
216
217
217
236
240
241
241
241
271
272
272
273
300
393
395
425
430
9
9
9
63
10
11
11
11
11111110639994304253953933002732722722712412412412402362172172162162041991971971961961781781731731561561461451451451311291001009685831717170161,6291,5791,5791,5671021021021121126206262626262626262626262626262626263636363636363635959595959595959000
   Retained Earnings Total Equity000-942,96600-988,1000-1,051,360-1,008,400-960,980-918,328-878,945-836,858-804,247-752,2700-645,986-614,019-558,783-519,276-479,885-444,280-411,061-386,659-365,232-350,567-330,890-309,702-286,866-261,850-240,756-219,827-202,344-182,872-155,644-134,750-118,447-100,615-89,716-80,533-72,153-64,499-58,489-52,113-46,386-42,133-30,283-16,993-2,108-2,0290000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
-336
-347
-357
-368
-370
-380
-390
4
-1
-2
-37
-51
-65
-58
-41
-47
-41
-466
-477
-487
-498
-501
-511
-523
-535
-548
-560
-572
-584
-596
-609
-621
0
0
0
0
0
0
0
-30
-49
-134
-70
-89
-109
-109
0
0
-82
-96
-111
-125
-61
-65
-73
-102
-94
-101
-109
-116
-123
-130
-137
-145
-153
-161
-172
-198
-231
-264
-300
-335
-372
-411
-451
-494
-554
-620
-687
-777
-969
-1,168
-1,356
-1,545
0
-1,935
-2,140
0
0
0
-58
0
-58
-58
-58
0
0
00-58-58-580-58000-2,140-1,9350-1,545-1,356-1,168-969-777-687-620-554-494-451-411-372-335-300-264-231-198-172-161-153-145-137-130-123-116-109-101-94-102-73-65-61-125-111-96-8200-109-109-89-70-134-49-300000000-621-609-596-584-572-560-548-535-523-511-501-498-487-477-466-41-47-41-58-65-51-37-2-14-390-380-370-368-357-347-336000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,661
1,661
15,198
26,846
41,333
50,310
50,580
98,302
102,834
134,096
135,086
136,321
137,952
181,892
182,983
243,187
245,704
279,724
282,712
423,932
428,903
433,024
436,995
441,026
443,953
514,500
516,351
518,147
521,608
613,864
616,560
619,235
621,872
624,516
704,351
706,789
709,886
720,551
754,644
908,457
911,511
950,615
957,309
0
962,025
0
0
974,980
0
0
0
000974,98000962,0250957,309950,615911,511908,457754,644720,551709,886706,789704,351624,516621,872619,235616,560613,864521,608518,147516,351514,500443,953441,026436,995433,024428,903423,932282,712279,724245,704243,187182,983181,892137,952136,321135,086134,096102,83498,30250,58050,31041,33326,84615,1981,6611,6610000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
794
590
815
825
703
713
723
333
407
407
390
367
362
358
351
314
287
734
715
654
573
573
584
596
583
596
608
620
632
644
657
669
0
332
485
485
496
496
496
30
49
134
70
1,701
0
1,770
1,661
1,661
15,280
26,942
41,443
42,078
50,641
98,368
102,907
134,197
135,180
136,422
138,061
182,008
183,106
243,317
245,841
279,868
282,865
424,093
429,075
433,222
437,226
441,290
444,253
514,835
516,724
518,557
522,060
614,358
617,114
619,855
622,559
625,293
705,320
707,957
711,242
722,097
754,644
910,392
913,651
950,615
957,309
959,792
962,025
949,076
358
974,980
976,566
976,799
978,917
978,917976,799976,566974,980358949,076962,025959,792957,309950,615913,651910,392754,644722,097711,242707,957705,320625,293622,559619,855617,114614,358522,060518,557516,724514,835444,253441,290437,226433,222429,075424,093282,865279,868245,841243,317183,106182,008138,061136,422135,180134,197102,90798,36850,64142,07841,44326,94215,2801,6611,6611,77001,7017013449304964964964854853320669657644632620608596583596584573573654715734287314351358362367390407407333723713703825815590794000



Balance Sheet

All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,302
Cost of Revenue-922
Gross Profit380380
 
Operating Income (+$)
Gross Profit380
Operating Expense-8,903
Operating Income-8,523-8,523
 
Operating Expense (+$)
Research Development0
Selling General Administrative18,963
Selling And Marketing Expenses0
Operating Expense8,90318,963
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income-8,523
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-7,742-9,304
EBIT - interestExpense = -8,523
-10,321
-10,278
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-8,523-7,742
Earnings Before Interest and Taxes (EBITDA)-7,601
 
After tax Income (+$)
Income Before Tax-7,742
Tax Provision-0
Net Income From Continuing Ops42,295-7,742
Net Income-10,278
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses9,825
Total Other Income/Expenses Net7810
 

Technical Analysis of Therapeuticsmd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Therapeuticsmd. The general trend of Therapeuticsmd is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Therapeuticsmd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of TherapeuticsMD Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.95 < 2 < 2.

The bearish price targets are: .

Tweet this
TherapeuticsMD Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of TherapeuticsMD Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

TherapeuticsMD Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of TherapeuticsMD Inc. The current macd is -0.11658885.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Therapeuticsmd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Therapeuticsmd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Therapeuticsmd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
TherapeuticsMD Inc Daily Moving Average Convergence/Divergence (MACD) ChartTherapeuticsMD Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of TherapeuticsMD Inc. The current adx is 28.30.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Therapeuticsmd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
TherapeuticsMD Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of TherapeuticsMD Inc. The current sar is 2.22083509.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
TherapeuticsMD Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of TherapeuticsMD Inc. The current rsi is 25.50. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 2/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending up: The RSI is trending up. +1
TherapeuticsMD Inc Daily Relative Strength Index (RSI) ChartTherapeuticsMD Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of TherapeuticsMD Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Therapeuticsmd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
TherapeuticsMD Inc Daily Stochastic Oscillator ChartTherapeuticsMD Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of TherapeuticsMD Inc. The current cci is -114.82462159.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
TherapeuticsMD Inc Daily Commodity Channel Index (CCI) ChartTherapeuticsMD Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of TherapeuticsMD Inc. The current cmo is -61.86897699.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
TherapeuticsMD Inc Daily Chande Momentum Oscillator (CMO) ChartTherapeuticsMD Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of TherapeuticsMD Inc. The current willr is -95.83333333.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
TherapeuticsMD Inc Daily Williams %R ChartTherapeuticsMD Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of TherapeuticsMD Inc.

TherapeuticsMD Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of TherapeuticsMD Inc. The current atr is 0.12188939.

TherapeuticsMD Inc Daily Average True Range (ATR) ChartTherapeuticsMD Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of TherapeuticsMD Inc. The current obv is 33,227,426.

TherapeuticsMD Inc Daily On-Balance Volume (OBV) ChartTherapeuticsMD Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of TherapeuticsMD Inc. The current mfi is 17.84.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
TherapeuticsMD Inc Daily Money Flow Index (MFI) ChartTherapeuticsMD Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for TherapeuticsMD Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-27SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-23CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-10BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-17MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-19MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

TherapeuticsMD Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of TherapeuticsMD Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5025.497
Ma 20Greater thanMa 502.109
Ma 50Greater thanMa 1002.248
Ma 100Greater thanMa 2002.294
OpenGreater thanClose1.870
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Therapeuticsmd with someone you think should read this too:
  • Are you bullish or bearish on Therapeuticsmd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Therapeuticsmd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about TherapeuticsMD Inc

I send you an email if I find something interesting about TherapeuticsMD Inc.


Comments

How you think about this?

Leave a comment

Stay informed about TherapeuticsMD Inc.

Receive notifications about TherapeuticsMD Inc in your mailbox!